MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s12072-024-10774-3

Медицинская библиотека · Hepatology international · 2025

The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease.

Eslam Mohammed, Fan Jian-Gao, Yu Ming-Lung, Wong Vincent Wai-Sun, Cua Ian Homer, Liu Chun-Jen, Tanwandee Tawesak, Gani Rino, Seto Wai-Kay, Alam Shahinul, Young Dan Yock, Hamid Saeed, Zheng Ming-Hua, Kawaguchi Takumi, Chan Wah-Kheong, Payawal Diana, Tan Soek-Siam, Goh George Boon-Bee, Strasser Simone I, Viet Hang Dao, Kao Jia-Horng, Kim Won, Kim Seung Up, Keating Shelley E, Yilmaz Yusuf, Kamani Lubna, Wang Chia-Chi, Fouad Yasser, Abbas Zaigham, Treeprasertsuk Sombat, Thanapirom Kessarin, Al Mahtab Mamun, Lkhagvaa Undram, Baatarkhuu Oidov, Choudhury Ashok Kumar, Stedman Catherine A M, Chowdhury Abhijit, Dokmeci A Kadir, Wang Fu-Sheng, Lin Han-Chieh, Huang Jee-Fu, Howell Jess, Jia Jidong, Alboraie Mohamed, Roberts Stuart K, Yoneda Masato, Ghazinian Hasmik, Mirijanyan Aram, Nan Yuemin, Lesmana Cosmas Rinaldi Adithya, Adams Leon A, Shiha Gamal, Kumar Manoj, Örmeci Necati, Wei Lai, Lau George, Omata Masao, Sarin Shiv K, George Jacob

СтатьяКлинические рекомендацииПеревод пока не подготовлен

Аннотация

Metabolic dysfunction-associated fatty liver disease (MAFLD) affects over one-fourth of the global adult population and is the leading cause of liver disease worldwide. To address this, the Asian Pacific Association for the Study of the Liver (APASL) has created clinical practice guidelines focused on MAFLD. The guidelines cover various aspects of the disease, such as its epidemiology, diagnosis, screening, assessment, and treatment. The guidelines aim to advance clinical practice, knowledge, and research on MAFLD, particularly in special groups. The guidelines are designed to advance clinical practice, to provide evidence-based recommendations to assist healthcare stakeholders in decision-making and to improve patient care and disease awareness. The guidelines take into account the burden of clinical management for the healthcare sector.

Для цитирования: Eslam Mohammed, Fan Jian-Gao, Yu Ming-Lung, Wong Vincent Wai-Sun, Cua Ian Homer, Liu Chun-Jen, Tanwandee Tawesak, Gani Rino, Seto Wai-Kay, Alam Shahinul, Young Dan Yock, Hamid Saeed, Zheng Ming-Hua, Kawaguchi Takumi, Chan Wah-Kheong, Payawal Diana, Tan Soek-Siam, Goh George Boon-Bee, Strasser Simone I, Viet Hang Dao, Kao Jia-Horng, Kim Won, Kim Seung Up, Keating Shelley E, Yilmaz Yusuf, Kamani Lubna, Wang Chia-Chi, Fouad Yasser, Abbas Zaigham, Treeprasertsuk Sombat, Thanapirom Kessarin, Al Mahtab Mamun, Lkhagvaa Undram, Baatarkhuu Oidov, Choudhury Ashok Kumar, Stedman Catherine A M, Chowdhury Abhijit, Dokmeci A Kadir, Wang Fu-Sheng, Lin Han-Chieh, Huang Jee-Fu, Howell Jess, Jia Jidong, Alboraie Mohamed, Roberts Stuart K, Yoneda Masato, Ghazinian Hasmik, Mirijanyan Aram, Nan Yuemin, Lesmana Cosmas Rinaldi Adithya, Adams Leon A, Shiha Gamal, Kumar Manoj, Örmeci Necati, Wei Lai, Lau George, Omata Masao, Sarin Shiv K, George Jacob. The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease.. Hepatology international. 2025. DOI: 10.1007/s12072-024-10774-3.

Предметные рубрики MeSH

HumansFatty LiverNon-alcoholic Fatty Liver Disease
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.